Skip to main content
Equibles

IMC-Chicago, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1452861 CHICAGO, IL
Back to INO Full portfolio

Position in INO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$65,926
+$65,926 QoQ
Shares Held
37,889
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Sep 30, 2021
CallValue
$2,342,751
CallShares
27,267
PutValue
$1,225,075
PutShares
14,258

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

IMC-Chicago, LLC holds $54,107,382 across 30 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 87,392 $11,645,857
2 INSM
INSMED Inc
 76,126 $8,116,554
3 MDGL
Madrigal Pharmaceuticals, Inc.
 10,847 $5,824,296
4 CELC
Celcuity Inc.
 41,127 $4,302,706
5 REGN
Regeneron Pharmaceuticals, Inc.
 5,591 $3,486,212
6 BNTX
BioNTech SE
 29,282 $2,724,690
7 AXSM
Axsome Therapeutics, Inc.
 10,187 $2,493,471
8 ROIV
Roivant Sciences Ltd.
 68,630 $2,428,815

All Filings in INO

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $65,926 37,889
2021-09-30 $2,342,751 327,200
2021-09-30 $1,225,075 171,100
2020-12-31 $304,776 34,438
2020-06-30 $718,567 26,663